Form 4: Kodiak Sciences Director Robert Profusek Granted 40,000 Stock Options

Kodiak Sciences Inc. Director Robert Profusek was granted 40,000 stock options with an exercise price of $3.73, vesting upon continued service.

Summary

• Robert Profusek, a Director at Kodiak Sciences Inc. (KOD), was granted 40,000 stock options.
• The stock options have an exercise price of $3.73 per share.
• The grant date for these options was June 30, 2025.
• The options are set to expire on June 29, 2035.
• The shares subject to the option will vest 100% upon the earlier of June 30, 2026, or one day prior to the Issuer's next annual meeting occurring after the grant date, contingent on Robert Profusek's continued service as a member of the board of directors through the applicable vesting date.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is generally viewed positively as it aligns the director's interests with shareholder value, encouraging long-term commitment and performance. This is a standard compensation practice.

Positives

• The grant of 40,000 stock options to a director aligns their interests with long-term shareholder value, encouraging commitment and performance.
• The exercise price of $3.73 per share indicates the value at the time of the grant.

Future Outlook

The vesting schedule for the granted options extends to June 30, 2026, or the next annual meeting, indicating an expectation of continued service from the director.

Industry Context

This Form 4 filing reports a routine insider transaction related to director compensation, which is a standard practice across industries to align management and board interests with shareholder value. It does not provide information on broader industry trends or competitive landscape.

Related Party Transactions

• Grant of 40,000 stock options to Robert Profusek, a Director of Kodiak Sciences Inc., as part of his compensation.

Stakeholder Impact

• Shareholders: Potential for future dilution if options are exercised, but also improved alignment of director interests with long-term company performance.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Vesting of 40,000 stock options upon continued service as a director, expected by June 30, 2026, or prior to the next annual meeting.
• Potential exercise of vested stock options by the director before the expiration date of June 29, 2035.

Key Dates

Keywords

Kodiak Sciences, KOD, stock options, director compensation, SEC Form 4, insider transaction, equity grant